하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
HIRONIC Inc. (CEO Jinwoo Lee), a leading manufacturer of medical aesthetic devices, has launched “SYNERJET,” a needle-free microjet system designed to reduce pain and post-procedural discomfort in aesthetic treatments. The device delivers active ingredients into the skin using high-pressure micro air streams, offering patients a less invasive alternative to traditional injections.
The development of SYNERJET addresses growing concerns among patients about the pain and bruising commonly associated with needle-based treatments. By utilizing a combination of needle-free microjet diffusion, plasma, and electroporation technology, SYNERJET enhances skin absorption while minimizing tissue trauma. This technology is gaining attention for its ability to improve recovery comfort and deliver more complete rejuvenation outcomes.
Dr. Byungwook Kim, Chief Director of Seoul All-Up Dermatology Clinic, stated in a recent interview, “Demand is rapidly increasing in the aesthetic market for solutions that reduce pain and recovery time. The needle-free microjet technology is a promising response to these evolving expectations.” He added, “While traditional injection methods may vary in discomfort depending on practitioner skill, SYNERJET offers shorter treatment times and lower pain levels, resulting in higher patient satisfaction.”
Experts believe this needle-free approach could serve as a suitable option for patients with needle anxiety or those requiring minimal downtime post-treatment. However, they also emphasize the importance of consulting medical professionals, as effectiveness may vary based on individual skin conditions and indications.
